Rajput et al found that TLR4 activation promotes carcinogenesis and resistance to chemical treatments in breast cancer [13], [14], whereas blocking TLR4 activation can slow breast cancer growth and prolong survival [20]. The gene discussed is TLR4; the disease is breast carcinoma.